AI Generated Image
New cholesterol treatment could be 'game changer' for Spokane, says MultiCare cardiologist
The Spokesman-Review • • health
Key Points:
- The FDA approved Lipfendra, a daily pill that can reduce high cholesterol by 50% to 60%, potentially transforming treatment for over 86 million Americans with high cholesterol.
- Lipfendra works alongside statins by inhibiting the PCSK9 enzyme, allowing the liver to better remove existing cholesterol from the blood, addressing cholesterol buildup that increases heart attack and stroke risk.
- Clinical trials showed Lipfendra is effective and has side effects similar to a placebo, with common issues including dizziness and diarrhea; it is expected to be available within weeks at a lower cost than the injectable version.
- Experts highlight that high cholesterol often results from genetics and lifestyle changes alone are usually insufficient, making Lipfendra a promising addition to current treatments for many patients.
- The oral form of Lipfendra is seen as a "game changer" due to easier administration and affordability compared to the injectable version, which has been available but costly and difficult to manage.
